Cargando…
MicroRNAS in endometrial cancer: recent advances and potential clinical applications
Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are useful for early and accurate diagnosis and few treatments other than surgery. However, use of microRNAs (miRNAs) that induces gene downregulation in cells may permit effective and minimally invasive...
Autores principales: | Yanokura, Megumi, Banno, Kouji, Iida, Miho, Irie, Haruko, Umene, Kiyoko, Masuda, Kenta, Kobayashi, Yusuke, Tominaga, Eiichiro, Aoki, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614112/ https://www.ncbi.nlm.nih.gov/pubmed/26535032 http://dx.doi.org/10.17179/excli2014-590 |
Ejemplares similares
-
Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer
por: UMENE, KIYOKO, et al.
Publicado: (2015) -
Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
por: Banno, Kouji, et al.
Publicado: (2015) -
ARID1A gene mutation in ovarian and endometrial cancers (Review)
por: TAKEDA, TAKASHI, et al.
Publicado: (2016) -
Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis
por: Takeda, Takashi, et al.
Publicado: (2016) -
Current status of molecular-targeted drugs for endometrial cancer (Review)
por: NOGAMI, YUYA, et al.
Publicado: (2013)